Prescription patterns of drugs inhibiting the renin-angiotensin-aldosterone-system (RAAS) in the Federal State of Saxony – an analysis of the AOK health insurance service database in the years 2003 and 2004

Melanie Kosa, Joachim Siegert, Beate Brecht, Jane Schröder, Ulf Maywald, Wilhelm Kirch & Christoph Schindler
Background and aim: RAAS-blockade plays a pivotal role not only in the management of arterial hypertension but also in congestive heart failure, post myocardial infarction and nephropathy with albuminuria, especially in diabetic patients. However, so far little is known about the physicians’ [for full text, please go to the a.m. URL]